DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | NDAQ

Overview

Corporate Details

ISIN(s):: US24661P8077
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ORTHOPEDIATRICS CORP Designs, develops, and markets orthopedic implants and instruments exclusively for children.	United States of America	KIDS
OSANG HEALTHCARE CO.,LTD. Develops and manufactures IVD medical devices and biosensors for diabetes management and health monitoring.	South Korea	036220
OssDsign AB Develops and markets nanosynthetic bone graft putty for spinal fusion surgery.	Sweden	OSSD
OSTEONIC Co., Ltd. Manufactures metal & biodegradable bone fixation implants for CMF, trauma & sports medicine.	South Korea	226400
Otofarma S.p.A. Provides tailored hearing solutions and remote diagnostics through a partner pharmacy network.	Italy	OTO
Outset Medical, Inc. Reduces dialysis complexity with an all-in-one, connected system for care from the ICU to home.	United States of America	OM
PARAMOUNT BED HOLDINGS CO.,LTD. Manufactures medical beds and furniture for hospitals, nursing facilities, and home care.	Japan	7817
Paul Hartmann AG Provides medical and hygiene solutions for wound, incontinence, and infection management.	Germany	PHH2
PAVmed Inc. A med-tech firm offering diagnostics for esophageal precancer & digital health for cancer care.	United States of America	PAVM
Paxman AB Specializing in scalp cooling systems to minimize hair loss for chemotherapy patients.	Sweden	PAX